Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...
MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
Moderna said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ...
It was a week of patent cases going to trial in the pharmaceutical industry. Pfizer, AstraZeneca, and Moderna all were ...
Covid-19 sub-variants, nicknamed "FLiRT", have been the dominant forms of the virus circulating this year globally, according ...